A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
Not specified
Study Completion Date
February 28, 1995
Conditions
HIV Infections
Interventions
DRUG
Zidovudine
DRUG
Aldesleukin
Trial Locations (1)
27710
Duke Univ. Med. Ctr. Adult CRS, Durham
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00001005 - A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes | Biotech Hunter | Biotech Hunter